Prof. Nir Giladi
Research work
Prof. Giladi's research interests are in the field of gait, falls, cognition, and genetics in Parkinson's Disease. Over the past two decades, he has devoted much of his time to research regarding unique aspects of gait, the prodromal stage of Parkinson's Disease, focusing on biological markers of early detection and predicting the conversion from a subject at risk to a patient with Parkinson's Disease.
Areas of interest & scientific knowledge
Brain Disorders Research
Clinical Neuroscience
Selected Publications
- Mirelman A, Bonato P, Camicioli R, Ellis TD, Giladi N, Hamilton JL, Hass CJ, Hausdorff JM, Pelosin E, Almeida QJ. Gait impairments in Parkinson's disease. Lancet Neurol. 2019 Jul; 18(7):697-708.
- Kozlovski T, Mitelpunkt A, Thaler A, Gurevich T, Orr-Urtreger A, Gana-Weisz M, Shachar N, Galili T, Marcus-Kalish M, Bressman S, Marder K, Giladi N, Benjamini Y, Mirelman A. Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's Disease. Front Neurol. 2019 May 21;10:531
- Jacob Y, Rosenberg-Katz K, Gurevich T, Helmich RC, Bloem BR, Orr-Urtreger A, Giladi N, Mirelman A, Hendler T, Thaler A. Network abnormalities among non-manifesting Parkinson disease related LRRK2 mutation carriers. Hum Brain Mapp. 2019 Jun 1;40(8):2546-2555.
- Kestenbaum M, Abu Snineh M, Nussbaum T, Gadoth A, Rosenberg A, Hindi A, Zitser J, Thaler A, Giladi N, Gurevich T. Repeated Intravenous Amantadine Infusions in Advanced Parkinsonism: Experience of a Large Movement Disorder Center. Isr Med Assoc J. 2019 Dec; 12(21):812-816.
- Rozani V, Gurevich T, Giladi N, El-Ad B, Tsamir J, Hemo B, Peretz C. Higher serum cholesterol and decreased Parkinson's disease risk: A statin-free cohort study Mov Disord. 2018 Aug 25. doi: 10.1002
